Her primary areas of investigation include Immunology, Vaccination, Antibody, Streptococcus pneumoniae and Conjugate vaccine. Her Immunology research is multidisciplinary, incorporating perspectives in Pneumococcal conjugate vaccine, Pneumococcal infections and Virology. Helena Käyhty has included themes like Booster dose, Immunization, Immunogenicity, Internal medicine and Pediatrics in her Vaccination study.
Her study in Antibody is interdisciplinary in nature, drawing from both Diphtheria toxin, Serotype, Microbiology and Saliva. Her research integrates issues of Avidity, Pneumonia and Streptococcaceae in her study of Streptococcus pneumoniae. Her Conjugate vaccine research includes elements of Haemophilus influenzae, Antibody titer, Licensure, Diphtheria and Toxoid.
Helena Käyhty mostly deals with Immunology, Antibody, Vaccination, Streptococcus pneumoniae and Microbiology. Her Immunology study combines topics from a wide range of disciplines, such as Pneumococcal conjugate vaccine, Haemophilus influenzae and Virology. In her work, Chronic lymphocytic leukemia is strongly intertwined with Serotype, which is a subfield of Antibody.
Her Vaccination study integrates concerns from other disciplines, such as Polysaccharide Vaccine, Immunization, Internal medicine and Pediatrics. Her research in the fields of Pneumococcal infections and Pneumococcal vaccine overlaps with other disciplines such as Carriage. The Microbiology study combines topics in areas such as Pneumolysin, Neisseria meningitidis, Bacterial capsule, Saliva and Immunoglobulin M.
Her scientific interests lie mostly in Streptococcus pneumoniae, Immunology, Vaccination, Pneumococcal conjugate vaccine and Antibody. Her Streptococcus pneumoniae study also includes
The various areas that Helena Käyhty examines in her Vaccination study include Immunoglobulin G, Immune system, Pediatrics and Pneumococcal polysaccharide vaccine. Her Pneumococcal conjugate vaccine study incorporates themes from Colonisation, Streptococcus pneumoniae vaccine, Vaccine efficacy, Pneumococcal infections and Conjugate vaccine. In her study, Chronic lymphocytic leukemia is strongly linked to Serotype, which falls under the umbrella field of Antibody.
Helena Käyhty mainly investigates Streptococcus pneumoniae, Immunology, Haemophilus influenzae, Microbiology and Pneumonia. Her Streptococcus pneumoniae research focuses on Antigen and how it relates to Serology and Antibody. Her study in the field of Immunoassay is also linked to topics like Multiplex.
Her Immunology research integrates issues from Pneumococcal vaccine and Virology. Her biological study spans a wide range of topics, including Observational study, Immunodeficiency, Serotype, Natural history and Pediatrics. Helena Käyhty works on Immunization which deals in particular with Conjugate vaccine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Eskola J;Kilpi T;Palmu A;Jokinen J.
The New England Journal of Medicine (2001)
The fundamental link between pneumococcal carriage and disease
Birgit Simell;Kari Auranen;Helena Käyhty;David Goldblatt.
Expert Review of Vaccines (2012)
Reduction of Oropharyngeal Carriage of Haemophilus influenzae Type b (Rib) in Children Immunized with an Rib Conjugate Vaccine
Aino K. Takala;Juhani Eskola;Maija Leinonen;Helena Kayhty.
The Journal of Infectious Diseases (1991)
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.
H Peltola;H Käyhty;M Virtanen;P H Mäkelä.
The New England Journal of Medicine (1984)
Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
Heikki Peltola;P. Helena Mäkelä;Helena Käyhty;Hannele Jousimies.
The New England Journal of Medicine (1977)
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
J Eskola;H Käyhty;A K Takala;H Peltola.
The New England Journal of Medicine (1990)
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
Luis Jódar;Jay Butler;George Carlone;Ron Dagan.
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.
Catherine M. Wernette;Carl E. Frasch;Dace Madore;George Carlone.
Clinical and Vaccine Immunology (2003)
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
J Eskola;H Peltola;A K Takala;H Käyhty.
The New England Journal of Medicine (1987)
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen.
Clinical Infectious Diseases (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: